Prokidney (PROK) Consolidated Net Income (2021 - 2026)

Prokidney (PROK) reported Consolidated Net Income of -$42.6 million for Q1 2026, down 12.3% year-over-year from -$48.6 million in Q1 2025, and down 4.33% quarter-over-quarter from -$40.9 million in Q4 2025.

Prokidney (PROK) Consolidated Net Income (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Consolidated Net Income data on file, last reported at -$42.6 million in Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$42.6 million, down 12.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$156.3 million (up 5.83% YoY), and the FY2025 annual result was -$151.6 million, up 7.18% from the prior year.
  • Consolidated Net Income fell to -$42.6 million in Q1 2026 per PROK's latest filing, from -$40.9 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at -$21.7 million in Q4 2023 and troughed at -$67.5 million in Q1 2022.
  • A 5-year average of -$37.7 million and a median of -$37.0 million in 2025 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2022 and 2023: Consolidated Net Income tumbled 1302215.71% in 2022, then soared 45.31% in 2023.
  • A 5-year view of Consolidated Net Income shows it stood at -$24.6 million in 2022, then gained by 11.59% to -$21.7 million in 2023, then sank by 123.18% to -$48.5 million in 2024, then rose by 15.74% to -$40.9 million in 2025, then declined by 4.33% to -$42.6 million in 2026.
  • Business Quant data shows PROK's Consolidated Net Income at -$42.6 million in Q1 2026, -$40.9 million in Q4 2025, and -$35.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Prokidney 259.01 Mn 1.55 Bn - -42.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -42.62 Mn
Dec 31, 2025 -40.85 Mn
Sep 30, 2025 -35.84 Mn
Jun 30, 2025 -36.97 Mn
Mar 31, 2025 -37.95 Mn
Dec 31, 2024 -48.48 Mn
Sep 30, 2024 -41.05 Mn
Jun 30, 2024 -38.47 Mn
Mar 31, 2024 -35.33 Mn
Dec 31, 2023 -21.72 Mn
Sep 30, 2023 -41.99 Mn
Jun 30, 2023 -34.82 Mn
Mar 31, 2023 -36.91 Mn
Dec 31, 2022 -24.57 Mn
Sep 30, 2022 -33.95 Mn
Jun 30, 2022 -22.13 Mn
Mar 31, 2022 -67.49 Mn
Dec 31, 2021 -13.82 Mn
Sep 30, 2021 -17.02 Mn
Jun 30, 2021 -5,325.00